Clinical Trial: A Study to Assess Nicotine Uptake From a Menthol Electronic Nicotine Delivery System Product

U.S., Oct. 21 -- ClinicalTrials.gov registry received information related to the study (NCT07881848) titled 'A Study to Assess Nicotine Uptake From a Menthol Electronic Nicotine Delivery System Product' on Oct. 13.

Brief Summary: This will be a randomized, open-label, 2-way crossover, single-site study designed to evaluate elements of abuse liability (AL), including subjective effects and physiological measures (pharmacodynamics [PD]), and plasma nicotine uptake (pharmacokinetics [PK]) of Menthol ENDS investigational product (IP) relative to each participant's usual brand (UB) menthol cigarette. The study will be conducted in a confinement setting in generally healthy adult menthol cigarette smokers and dual users of menthol cigarettes and...